Welcome!

News Feed Item

Influenza Global Clinical Trials Review, H2, 2013



 

 

 

LONDON, March 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Influenza Global Clinical Trials Review, H2, 2013


Influenza Global Clinical Trials Review, H2, 2013


Summary

GlobalData's clinical trial report, "Influenza Global Clinical Trials Review, H2, 2013" provides data on the Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Influenza 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Influenza 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Influenza Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Sanofi 56
Clinical Trial Overview of Sanofi 56
MedImmune, LLC 61
Clinical Trial Overview of MedImmune, LLC 61
F. Hoffmann-La Roche Ltd. 65
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 65
CSL Limited 67
Clinical Trial Overview of CSL Limited 67
Baxter International Inc. 69
Clinical Trial Overview of Baxter International Inc. 69
Daiichi Sankyo Company, Limited 71
Clinical Trial Overview of Daiichi Sankyo Company, Limited 71
Crucell Holland B.V 72
Clinical Trial Overview of Crucell Holland B.V 72
BioCryst Pharmaceuticals, Inc. 73
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 73
Adimmune Corporation 74
Clinical Trial Overview of Adimmune Corporation 74
Sinovac Biotech Co., Ltd. 75
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 75
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Clinical Trial Overview of OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Novartis Vaccines and Diagnostics, Inc. 77
Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc. 77
Novavax, Inc. 78
Clinical Trial Overview of Novavax, Inc. 78
VaxInnate Corporation 79
Clinical Trial Overview of VaxInnate Corporation 79
Protein Sciences Corporation 80
Clinical Trial Overview of Protein Sciences Corporation 80
Abbott Laboratories 81
Clinical Trial Overview of Abbott Laboratories 81
Kaketsuken K.K. 82
Clinical Trial Overview of Kaketsuken K.K. 82
Pfizer Inc. 83
Clinical Trial Overview of Pfizer Inc. 83
Clinical Trial Overview of Top Institutes / Government 84
The National Institute of Allergy and Infectious Diseases 84
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 84
The University of Hong Kong 91
Clinical Trial Overview of The University of Hong Kong 91
University of Oxford 92
Clinical Trial Overview of University of Oxford 92
University Hospitals of Leicester NHS Trust 93
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 93
National Hospital Organization Mie National Hospital 94
Clinical Trial Overview of National Hospital Organization Mie National Hospital 94
Centers for Disease Control and Prevention 95
Clinical Trial Overview of Centers for Disease Control and Prevention 95
St. Jude Children's Research Hospital, Inc. 96
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 96
The University of British Columbia 97
Clinical Trial Overview of The University of British Columbia 97
University of the Witwatersrand 98
Clinical Trial Overview of University of the Witwatersrand 98
Program for Appropriate Technology in Health 99
Clinical Trial Overview of Program for Appropriate Technology in Health 99
University of Rochester 100
Clinical Trial Overview of University of Rochester 100
Columbia University 101
Clinical Trial Overview of Columbia University 101
Assistance Publique - Hopitaux de Paris 102
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 102
McMaster University 103
Clinical Trial Overview of McMaster University 103
Institut National de la Sante et de la Recherche Medicale 104
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 104
Queen Mary Hospital 105
Clinical Trial Overview of Queen Mary Hospital 105
University of Pittsburgh 106
Clinical Trial Overview of University of Pittsburgh 106
Hadassah Medical Organization 107
Clinical Trial Overview of Hadassah Medical Organization 107
University of Michigan 108
Clinical Trial Overview of University of Michigan 108
University of Alberta 109
Clinical Trial Overview of University of Alberta 109
Five Key Clinical Profiles 110
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164




List of Tables

Influenza Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries, 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries, 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Influenza Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Influenza Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 56
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 61
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 65
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2013* 67
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 69
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 71
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2013* 72
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2013* 73
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Adimmune Corporation, 2013* 74
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sinovac Biotech Co., Ltd., 2013* 75
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd., 2013* 76
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines and Diagnostics, Inc., 2013* 77
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2013* 78
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by VaxInnate Corporation, 2013* 79
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Protein Sciences Corporation, 2013* 80
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 81
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaketsuken K.K., 2013* 82
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 83
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 84
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 91
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 92
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 93
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2013* 94
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2013* 95
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2013* 96
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2013* 97
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2013* 98
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Program for Appropriate Technology in Health, 2013* 99
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 100
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 101
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 102
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 103
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2013* 104
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2013* 105
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 106
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 107
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 108
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 109

List of Figures
Influenza Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 162


Read the full report:
Influenza Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trial...

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Between the mockups and specs produced by analysts, and resulting applications built by developers, there exists a gulf where projects fail, costs spiral, and applications disappoint. Methodologies like Agile attempt to address this with intensified communication, with partial success but many limitations. In his session at 18th Cloud Expo, Charles Kendrick, CTO & Chief Architect at Isomorphic Software, will present a revolutionary model enabled by new technologies. Learn how business and devel...
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
The IoT has the potential to create a renaissance of manufacturing in the US and elsewhere. In his session at 18th Cloud Expo, Florent Solt, CTO and chief architect of Netvibes, will discuss how the expected exponential increase in the amount of data that will be processed, transported, stored, and accessed means there will be a huge demand for smart technologies to deliver it. Florent Solt is the CTO and chief architect of Netvibes. Prior to joining Netvibes in 2007, he co-founded Rift Technol...
Struggling to keep up with increasing application demand? Learn how Platform as a Service (PaaS) can streamline application development processes and make resource management easy.
If there is anything we have learned by now, is that every business paves their own unique path for releasing software- every pipeline, implementation and practices are a bit different, and DevOps comes in all shapes and sizes. Software delivery practices are often comprised of set of several complementing (or even competing) methodologies – such as leveraging Agile, DevOps and even a mix of ITIL, to create the combination that’s most suitable for your organization and that maximize your busines...
The increasing popularity of the Internet of Things necessitates that our physical and cognitive relationship with wearable technology will change rapidly in the near future. This advent means logging has become a thing of the past. Before, it was on us to track our own data, but now that data is automatically available. What does this mean for mHealth and the "connected" body? In her session at @ThingsExpo, Lisa Calkins, CEO and co-founder of Amadeus Consulting, will discuss the impact of wea...
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus inter...
See storage differently! Storage performance problems have only gotten worse and harder to solve as applications have become largely virtualized and moved to a cloud-based infrastructure. Storage performance in a virtualized environment is not just about IOPS, it is about how well that potential performance is guaranteed to individual VMs for these apps as the number of VMs keep going up real time. In his session at 18th Cloud Expo, Dhiraj Sehgal, in product and marketing at Tintri, will discu...
We’ve worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we’ll use over the next 5 years are already products, they’re just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
In his session at @ThingsExpo, Chris Klein, CEO and Co-founder of Rachio, will discuss next generation communities that are using IoT to create more sustainable, intelligent communities. One example is Sterling Ranch, a 10,000 home development that – with the help of Siemens – will integrate IoT technology into the community to provide residents with energy and water savings as well as intelligent security. Everything from stop lights to sprinkler systems to building infrastructures will run ef...
SYS-CON Events announced today that Enzu, a leading provider of cloud hosting solutions, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to foc...
SYS-CON Events announced today that Stratoscale, the software company developing the next generation data center operating system, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Stratoscale is revolutionizing the data center with a zero-to-cloud-in-minutes solution. With Stratoscale’s hardware-agnostic, Software Defined Data Center (SDDC) solution to store everything, run anything and scale everywhere...
Digital payments using wearable devices such as smart watches, fitness trackers, and payment wristbands are an increasing area of focus for industry participants, and consumer acceptance from early trials and deployments has encouraged some of the biggest names in technology and banking to continue their push to drive growth in this nascent market. Wearable payment systems may utilize near field communication (NFC), radio frequency identification (RFID), or quick response (QR) codes and barcodes...
Angular 2 is a complete re-write of the popular framework AngularJS. Programming in Angular 2 is greatly simplified – now it's a component-based well-performing framework. This immersive one-day workshop at 18th Cloud Expo, led by Yakov Fain, a Java Champion and a co-founder of the IT consultancy Farata Systems and the product company SuranceBay, will provide you with everything you wanted to know about Angular 2.